DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ surged 12.99% to $8.35 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.74% to 17,166.04 and the Dow Jones Industrial Average rising 1.23% to 40,093.40.
This was the stock's fifth consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 86.51% below its 52-week high of $61.90, which the company achieved on July 31st.
The stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.46% to $4.31, Fortress Biotech Inc. (FBIO) rose 5.06% to $1.66, and Viking Therapeutics Inc. $(VKTX)$ fell 0.50% to $25.66.
Trading volume (268,235) eclipsed its 50-day average volume of 230,477.
Data source: Dow Jones Market Data, FactSet. Data compiled April 24, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 24, 2025 17:22 ET (21:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。